Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Non-Current Deferred Tax Liability: 2020-2025

Historic Non-Current Deferred Tax Liability for Maravai Lifesciences Holdings (MRVI) over the last 1 years, with Jun 2025 value amounting to $2.0 million.

  • Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability was N/A to $2.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $11,000 for FY2024, which is N/A change from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Non-Current Deferred Tax Liability stood at $2.0 million for Q2 2025, which was up 2.74% from $2.0 million recorded in Q1 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Non-Current Deferred Tax Liability peaked at $8.7 million during Q1 2023, and registered a low of $11,000 during Q4 2024.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Non-Current Deferred Tax Liability value was $4.4 million (recorded in 2023), while the average stood at $4.6 million.